ArticleOncogene2023
MAD2 activates IGF1R/PI3K/AKT pathway and promotes cholangiocarcinoma progression by interfering USP44/LIMA1 complex.
Wangjie Jiang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it
ArticleOncogene2023
Wangjie Jiang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.